Select Page

Novo Nordisk Foundation, Wellcome & the Gates Foundation announce new R&D partnership

At this year´s Novo Nordisk Foundation’s Global Science Summit in Denmark, Novo Nordisk Foundation, Wellcome & the Gates Foundation each committed USD 100 million to support solutions to address the health impacts of climate change; infectious disease and antimicrobial resistance (AMR); and greater understanding of the interplay between nutrition, immunity, disease, and developmental outcomes.

“By pooling the vast experience and unique expertise of each organization – across research, technology, innovation, and enterprise – we can make advances that wouldn’t otherwise be possible,” says Mads Krogsgaard Thomsen, CEO, Novo Nordisk Foundation.

“We’re on the cusp of so many scientific breakthroughs in agriculture, health, and nutrition, and with the right support these innovations will save and improve lives around the world,” says Mark Suzman, CEO of the Bill & Melinda Gates Foundation. “Every sector has a critical role to play, and we hope this collaboration opens the door for other funders and partners to contribute to scaling up existing innovations and developing the tools of tomorrow.”

For the full article, please refer to Nordic Life Science News.

Most recent news